CASI Pharmaceuticals Inc. (CASI)
(Delayed Data from NSDQ)
$6.59 USD
+0.05 (0.76%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $6.52 -0.07 (-1.06%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.62 | 0.00% |
Earnings Summary
For their last quarter, CASI Pharmaceuticals Inc. (CASI) reported earnings of -$0.52 per share, beating the Zacks Consensus Estimate of $-0.63 per share. This reflects a positive earnings surprise of 17.46%. Look out for CASI's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.62 per share, reflecting a year-over-year decrease of 77.14%.
Earnings History
Price & Consensus
Zacks News for CASI
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2
CASI: What are Zacks experts saying now?
Zacks Private Portfolio Services